Statistics
Publications
1
Citations
88
H-Index
1
Active since
2023
Affiliations
Hetal S Randeria is an author at Loxo Oncology at Lilly (United States) specializing in ligand binding, protein kinase inhibitors, and enzyme inhibition.
Publications per year
2023–2023
1
1
1–1 of 1